Aids Malignancy Consortium
Clinical trials sponsored by Aids Malignancy Consortium, explained in plain language.
-
Old HIV drug shows promise against rare skin cancer
Disease control CompletedThis study tested whether nelfinavir, a drug originally used for HIV, can shrink Kaposi sarcoma tumors in the skin. 36 adults with Kaposi sarcoma (some HIV-positive, some HIV-negative) took the drug to see if it stopped cancer cell growth. The goal was to measure how many people …
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 17, 2026 02:43 UTC
-
New hope for HIV patients with kaposi sarcoma: drug shows promise in africa
Disease control CompletedThis study tested a drug called pomalidomide in 26 HIV-positive people with Kaposi sarcoma, a type of skin cancer. The drug works by boosting the immune system and blocking blood vessel growth to tumors. The goal was to see if it could shrink tumors and how safe it was. The trial…
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
HPV vaccine shows promise in cutting cervical cancer risk for HIV-Positive women
Disease control CompletedThis study tested whether the HPV vaccine can reduce high-grade cervical lesions (precancerous growths) in women living with HIV. About 536 women received either the HPV vaccine or a placebo, and researchers tracked how many developed serious cervical changes over one to two year…
Phase: PHASE3 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC
-
DNA vaccine shows promise against anal precancer in HIV patients
Disease control CompletedThis study tested a DNA-based vaccine called VGX-3100 in 44 HIV-positive adults with high-grade anal precancer caused by HPV types 16 or 18. The vaccine was given with a mild electric pulse (electroporation) to help cells absorb it and boost the immune system's attack on the abno…
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 10, 2026 13:25 UTC
-
New drug shows promise in cutting off kaposi Sarcoma's blood supply
Disease control CompletedThis study tested a drug called sEphB4-HSA in 23 people with Kaposi sarcoma, a type of skin cancer. The drug works by blocking the growth of blood vessels that feed the cancer and may also stop cancer cells from growing. The main goal was to see how many patients had a clinical r…
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 08, 2026 13:08 UTC
-
Less invasive surgery shows promise for anal cancer in HIV patients
Disease control CompletedThis study looked at whether removing small, early-stage anal cancers with local surgery alone is safe and effective for people with HIV. The goal was to see if this less invasive approach could avoid the need for stronger treatments like radiation or chemotherapy. Sixteen partic…
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 08, 2026 13:06 UTC
-
HIV cancer study reveals who gets sick and why
Knowledge-focused CompletedThis study looked at 460 people with HIV who came to cancer clinics across the U.S. to find out what types of cancer they had and why some chose to join cancer clinical trials. Researchers counted new and existing cancer cases and compared them to national data. The goal was to b…
Sponsor: AIDS Malignancy Consortium • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:49 UTC
-
HIV Patients' CAR T-Cell cancer treatment under the microscope
Knowledge-focused CompletedThis study looked back at 30 people with HIV who had already received a special cancer treatment called CAR T-cell therapy for certain blood cancers like leukemia or lymphoma. Researchers collected information from their medical records to see what side effects occurred and how t…
Sponsor: AIDS Malignancy Consortium • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:12 UTC
-
Small study tracks daily life impact of kaposi sarcoma treatment
Knowledge-focused CompletedThis study followed 10 people with HIV and AIDS-related Kaposi sarcoma in Tanzania to see how their quality of life changed during treatment with vincristine and bleomycin. Participants filled out questionnaires about their physical, emotional, social, and daily functioning over …
Sponsor: AIDS Malignancy Consortium • Aim: Knowledge-focused
Last updated Jun 01, 2026 18:07 UTC